Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Laurence Albiges MD, PhD

Laurence Albiges MD, PhD

Head, Genitourinary Unit, Gustave Roussy Institute, Villejuif, France

Dr Laurence Albiges, M.D., Ph.D., is a medical oncologist in the Genitourinary group of the Department of Cancer Medicine at the Institute Gustave Roussy, in France.

She trained in Paris, got her MD in 2010 as Medical Oncologist, and moved to the Genitourinary group at Gustave Roussy Institute in 2011. She completed her PhD.  focused on Papillary Renal Cancer in 2013. She subsequently moved as a visiting scientist at The Lank Center for Genitourinary oncology of the Dana-Farber Cancer Institute in 2013-2014.

Her main field of interest across genitourinary tumours is renal carcinoma and metastasis to the bone of renal and prostate cancer. She is developing translational programs within these settings.

 

She is a member of ASCO, ESMO. She is the recipient of several grants and awards including UNICANCER- Fondation de France grant, ASCO 2014 Annual meeting Merit Award and ASCO GU 2015 Symposium Merit Award.

Recent Contributions to PracticeUpdate:

  1. Subcutaneous vs Intravenous Nivolumab for Renal Cell Carcinoma: CheckMate 67T
  2. TiNivo: A Phase Ib Dose Escalation Trial of Tivozanib and Nivolumab in Renal Cell Carcinoma
  3. Non Clear Cell RCC: Bridging Translational Data to the Clinic Papillary RCC
  4. First-Line and Adjuvant Therapy for RCC—PracticeUpdate's ESMO 2016 Coverage

Recently Updated